American Herbal Products Association (AHPA) > Resources > Regulations > Government Advocacy

Recent AHPA Advocacy

AHPA submits GMO labeling recommendations to USDA

AHPA submits GMO labeling recommendations to USDA

USDA proposal would hinder consumer access to information on genetically modified foods

In an effort to ensure American consumers can discern if their food includes GMOs, AHPA recommended significant revisions to a proposed rule issued by USDA's Agricultural Marketing Service (AMS) to establish a mandatory, national bioengineered (BE) food disclosure standard.

AHPA represents member interests at Cosmetic Ingredient Review meeting

AHPA represents member interests at Cosmetic Ingredient Review meeting

AHPA attends Cosmetic Ingredient Review meeting finalizing Ginkgo biloba and eucalyptus cosmetic ingredient safety reports

American Herbal Products Association (AHPA) Chief Information Analyst Merle Zimmermann, Ph.D., attended the 147th Cosmetic Ingredient Review (CIR) Expert Panel Meeting on the safety of ingredients used in cosmetics held in Washington, D.C., Jun. 4-5. The meeting included discussions of two CIR safety reports being developed on Gingko biloba and eucalyptus cosmetic ingredients.
AHPA recommends oshá harvest permitting in GMUG National Forests

AHPA recommends oshá harvest permitting in GMUG National Forests

Research supported by the AHPA ERB Foundation concludes plants have a high capacity for post‐harvest recolonization

AHPA recently submitted comments to the Grand Mesa, Uncompahgre and Gunnison (GMUG) National Forests to recommend that a revision of its plan for land and resource management include a process for permitting commercial harvest of oshá (Ligusticum porteri) root.

AHPA endorses the Hemp Farming Act of 2018

AHPA Board adopts policy to support any state or federal efforts to decriminalize hemp

AHPA is endorsing federal legislation recently introduced to decriminalize hemp and the AHPA Board of Trustees has adopted a policy for the association to support any future state or federal legislation to decriminalize the plant and all its derivatives.

IADSA update on international supplement regulations

IADSA April 2018 Newsflash

This issue of the IADSA Newsflash includes an update on EFSA's proposed limit of 800 mg/day for the intake of green tea catechins in food supplements

AHPA President Michael McGuffin urges companies selling kratom to comply with all applicable laws and regulations

Statement delivered during press conference

AHPA President Michael McGuffin stressed that any company looking to sell kratom or kratom products must comply with all applicable laws and regulations during a press conference.

AHPA recommends CBD not be scheduled under any international drug control convention

AHPA submits comments to FDA to inform participation in WHO Expert Committee on Drug Dependence

AHPA submitted comments to the Food and Drug Administration (FDA) yesterday to stress that cannabidiol (CBD) requires no international drug scheduling as an individual substance and encourage the U.S. to support this position.
Rate of NDI notifications reported by FDA unexpectedly drops

Rate of NDI notifications reported by FDA unexpectedly drops

More than half of most recent NDI notifications available from FDA filed without comment

More than half of the most recent new dietary ingredient (NDI) notifications provided by the Food and Drug Administration (FDA) in the last six months were filed without comment, but the rate of notifications reported received by the agency is dramatically lower than previously observed for any six month period since the initial six months in 1995 when the agency first began accepting and filing notifications.

AHPA supports FDA Guidance making pure or highly concentrated caffeine dietary supplements unlawful

AHPA policy prohibits the sale of pure caffeine

FDA issued guidance titled, "Highly Concentrated Caffeine in Dietary Supplements: Guidance for Industry," to explain that it generally considers pure or highly concentrated caffeine dietary supplements, sold in bulk directly to consumers, to be adulterated because they present a significant or unreasonable risk of illness or injury. The principle in this guidance is consistent with a policy adopted by AHPA members in 2015.
AHPA staff participate in panels on pesticides and food adulteration prevention at GMA Science Forum

AHPA staff participate in panels on pesticides and food adulteration prevention at GMA Science Forum

AHPA President Michael McGuffin presented on a panel discussing pesticide issues

AHPA President Michael McGuffin and Chief Science Officer Holly Johnson, Ph.D. presented at the Grocery Manufacturers Association (GMA) Science Forum held this week in Washington, DC.
RSS
12345678910 Last

2018 Annual Fund Sponsors

   

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.